| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | injection | ÇÑ±Û | ÁÖÀÔ |
|---|---|---|---|
| ¼³¸í | ¾×ü¸¦ ÇÇÇÏÁ¶Á÷, Ç÷°ü, ¶Ç´Â Àå±â µî ¾î¶² ºÎºÐ¿¡ ¹Ð¾î ³Ö´Â °Í, ¶Ç´Â ±×·¯ÇÑ ¹æ¹ýÀ¸·Î Åõ¿©µÈ ¹°ÁúÀ» ¸»ÇÑ´Ù. |
||
| SI | International System of Units [Fr. le Systeme International d'Unites]; sacroiliac; saline infusion; ... |
|---|---|
| DMPA | depot medroxyprogesterone acetate |
| MPA | mean pulmonary arterial [pressure]; medial preoptic area; Medical Procurement Agency; medroxyprogest... |
| ICD | I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso... |
| EE | embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth... |
| MPA | Medroxyprogesterone |
|---|---|
| COC | Combined oral contraceptive |
| CVR | Contraceptive Vaginal Ring |
| ECP | Emergency Contraceptive Pills |
| IUCD | Intra Uterine Contraceptive Device |
| medroxyprogesterone | <chemical> (6 alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator. Pharmacological action: contraceptives, oral, synthetic, progestational hormones, synthetic. Chemical name: Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (12 Dec 1998) |
|---|---|
| medroxyprogesterone 17-acetate | <chemical> A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms. Pharmacological action: antineoplastic agent, hormonal, contraceptive agents, female, contraceptive agents, male, progestational hormones, synthetic. Chemical name: Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)- (12 Dec 1998) |
| medroxyprogesterone acetate | 17a-Hydroxy-6a-methylprogesterone;a progestational agent that is active orally as well as parenterally, and more potent than progesterone; used to control uterine bleeding and, in combination with ethynyl estradiol, as an oral contraceptive. (05 Mar 2000) |
| acyl-CoA-estradiol-17-beta-acyltransferase | <enzyme> Catalyses the esterification of estradiol with long chain fatty acids at the 17-position Registry number: EC 2.3.1.- Synonym: acylcoenzyme a-estradiol-17-beta-acyltransferase, estradiol 17-acyltransferase (26 Jun 1999) |
| receptors, estradiol | Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription. (12 Dec 1998) |
| estradiol | A hormone (272 D) synthesised mainly in the ovary, but also in the placenta, testis and possibly adrenal cortex. A potent oestrogen. (18 Nov 1997) |
| estradiol 15 alpha-hydroxylase | <enzyme> Catalyses the conversion of estradiol to 15alpha-hydroxyestradiol Registry number: EC 1.14.99.- Synonym: e15a-hydroxylase (26 Jun 1999) |
| estradiol 16 alpha-hydroxylase | <enzyme> Cyp2c11 is a male-specific cyp isoform Registry number: EC 1.14.99.- Synonym: 16 alpha-hydroxylase, estrone 16 alpha-hydroxylase, 16alpha-hydroxylase, steroid 16 alpha-hydroxylase, estrone 3-sulfate 16 alpha-hydroxylase, cytochrome p450cmf, cytochrome p450 2c, cytochrome p450iic11, cytochrome p450(ut-a), cytochrome p4502c-rml5, cytochrome p450h, cytochrome p450(male), cytochrome p4502c, cytochrome p450 2c3, cytochrome p450 2c9, oestrogen 16-hydroxylase, cyp2c3 gene product, cyp2c11 gene product, cytochrome p450 2c11, cyp 2d-9, cytochrome p450(tb), cyp2c9, cytochrome p-450(m1), cyp2c11 (26 Jun 1999) |
| estradiol-17 beta sulfotransferase | <enzyme> Specific for estradiol 17beta; not the same as EC 2.8.2.15 Registry number: EC 2.8.2.- (26 Jun 1999) |
| estradiol antagonists | Compounds which inhibit or antagonise the biosynthesis or action of estradiol. (12 Dec 1998) |
| estradiol benzoate unit | The oestrogenic activity of 0.1 ug of a standard preparation of estradiol benzoate. (05 Mar 2000) |
| estradiol dehydrogenases | <enzyme> Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration.2 Chemical name: Estradiol-17 beta:NAD(P)+ 17-oxidoreductase Registry number: EC 1.1.1.62 (12 Dec 1998) |
| estradiol receptor tyrosine kinase | <enzyme> Calcium and calmodulin dependent Registry number: EC 2.7.1.- Synonym: ertk (26 Jun 1999) |
| ethinyl estradiol | <chemical> (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol. A semisynthetic oestrogen with high oral oestrogenic potency. It is often used as the oestrogenic component in oral contraceptives. Pharmacological action: antineoplastic agent, hormonal, oestrogens, synthetic. Chemical name: 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)- (12 Dec 1998) |
| ethinyl estradiol-norgestrel combination | <chemical> Ethinyl estradiol and norgestrel given in fixed proportions. It has proved to be an effective contraceptive. Pharmacological action: contraceptives, oral, combined, contraceptives, oral, synthetic, contraceptives, postcoital, synthetic. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|